Donate | Español
Mar 20, 2012 - For patients with HIV-associated Kaposi's sarcoma, bevacizumab is tolerated and induces a response in some patients, according to a study published online March 19 in the Journal of Clinical Oncology.
Mar 20, 2012
View More News
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!